Results 1 to 10 of about 2,044 (190)

Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT‐MI [PDF]

open access: goldESC Heart Failure
Background In the EMPACT‐MI trial, empagliflozin did not reduce the primary endpoint of all‐cause mortality or hospitalization for heart failure (HHF) following acute myocardial infarction (AMI) but was associated with a risk reduction for HF events ...
Francesco Fioretti   +23 more
doaj   +6 more sources

Mobilizing the Power of Lived/Living Experiences to Improve Health Outcomes for all [PDF]

open access: yesHealth Expectations
Introduction Health Equity Assessments (HEAs) are decision‐support frameworks or tools used to evaluate the equity impacts of policies, programmes and initiatives.
Ambreen Sayani   +19 more
doaj   +3 more sources

Assessing the effects of Enhanced Multicomponent Proactive Navigator-Assisted Cessation of Tobacco Use within a federally qualified health center (EMPACT-Us): a protocol study [PDF]

open access: goldBMC Public Health
Background California’s relatively low smoking rate (10.1% in 2019–2020) (About CHIS, UCLA Center for Health Policy Research, 2024) masks deep disparities among low-income populations, where smoking rates are nearly double that of their middle- to upper ...
Gabriela Favela Ramirez   +11 more
doaj   +4 more sources

Az EMPACT szerepe a kiberbűncselekmények elleni küzdelemben

open access: diamondBelügyi Szemle, 2023
Cél: Az írás célja a nemzetközi bűnügyi együttműködésben kitűntetett szerepet betöltő és már állandó uniós eszköznek számító EMPACT platform struktúrájának, működésének, eredményeinek bemutatása a kiberbűnözés vonatkozásában.
Dániel Vetter
doaj   +4 more sources

Challenge-based education methodology within sustainable development environments: from ocean i3 to EmPACT i3 experience [PDF]

open access: goldFrontiers in Education
This paper discusses the application of challenge-based education (CBE) in sustainability contexts, based on the Ocean i3 and EmPACT i3 projects. Within the framework of the Sustainable Development Goals (SDGs), especially SDG 3, CBE is proposed as a way
Itziar Rekalde-Rodríguez   +4 more
doaj   +3 more sources

Impact of admission glucose and 30-day major adverse cardiovascular events on patients with chest pain in an emergency setting: insights from the China EMPACT registry [PDF]

open access: goldFrontiers in Cardiovascular Medicine
ObjectiveAlthough the association between admission glucose (AG) and major adverse cardiac events (MACE) is well-documented, its relationship with 30-day MACE in patients presenting with cardiac chest pain remains unclarified.
Xinxin Yin   +35 more
doaj   +4 more sources

Baseline characteristics of patients enrolled in the EMPACT‐MI trial [PDF]

open access: hybridEuropean Journal of Heart Failure, 2023
ABSTRACTAimsEmpagliflozin has been shown to reduce the risk of adverse cardiovascular outcomes in patients with type 2 diabetes and in those with heart failure. The impact of empagliflozin in post‐acute myocardial infarction (AMI) patients is unknown.Methods and resultsThe Study to Test the Effect of Empagliflozin on Hospitalization for Heart Failure ...
Josephine, Harrington   +10 more
openaire   +4 more sources

Making an Impact with E.M.P.A.C.T. Engage, Mentor Prepare, Advocate, Cultivate, and Teach: An Innovative Pilot Mentoring Program Evaluation for Students Underrepresented in Medicine [PDF]

open access: yesAdvances in Medical Education and Practice, 2023
Tracey L Henry,1 Christian D Freeman,2 Anisha Sheth,3 Lauren Jenkins,1 Oreoluwa E Olakunle,1 Segun Adeagbo,1 Mariana C Sanchez-Medina,1 Kara Alcegueire,4 Josué Rodríguez1 1Division of General Medicine, Emory University School of Medicine, Atlanta, GA ...
Henry TL   +8 more
doaj   +2 more sources

Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial [PDF]

open access: hybridAmerican Heart Journal, 2022
Patients with acute myocardial infarction (MI) are at risk for developing heart failure (HF) and subsequently are at an increased risk of mortality. Sodium-glucose cotransporter-2 inhibitors have been proven to improve outcomes in patients with HF with reduced ejection fraction, and, in the case of empagliflozin, in HF with preserved ejection fraction ...
Harrington, Josephine   +10 more
openaire   +3 more sources

The Empact CVT: modelling, simulation and experiments [PDF]

open access: greenInternational Journal of Modelling, Identification and Control, 2008
This paper shows the implementation of a simulation model for newelectromechanically actuated metal V-belt type continuously variabletransmission (CVT), referred to as the Empact CVT. An analysis ofthe dynamics of the actuation system and of the driveline shows thatthe eigenfrequencies of the system depend on both the CVT ratio andthe slip in the ...
Klaassen, T.W.G.L.   +6 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy